Annual Cash & Cash Equivalents
$532.20 K
+$217.40 K+69.06%
December 31, 2022
Summary
- As of February 8, 2025, SER annual cash & cash equivalents is $532.20 thousand, with the most recent change of +$217.40 thousand (+69.06%) on December 31, 2022.
- During the last 3 years, SER annual cash & cash equivalents has risen by +$217.40 thousand (+69.06%).
- SER annual cash & cash equivalents is now at all-time high.
Performance
SER Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.19 M
-$2.88 M-47.48%
September 30, 2024
Summary
- As of February 8, 2025, SER quarterly cash and cash equivalents is $3.19 million, with the most recent change of -$2.88 million (-47.48%) on September 30, 2024.
- Over the past year, SER quarterly cash and cash equivalents has stayed the same.
- SER quarterly cash and cash equivalents is now -63.48% below its all-time high of $8.72 million, reached on June 1, 2023.
Performance
SER Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SER Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.1% | 0.0% |
| 3 y3 years | +69.1% | - |
| 5 y5 years | +69.1% | - |
SER Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.1% | -63.5% | +498.5% |
| 5 y | 5-year | at high | +69.1% | -63.5% | +498.5% |
| alltime | all time | at high | +69.1% | -63.5% | +498.5% |
Serina Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.19 M(-47.5%) |
| Jun 2024 | - | $6.06 M(-30.3%) |
| Mar 2024 | - | $8.71 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $8.72 M(+1538.9%) |
| Dec 2022 | $532.20 K(+69.1%) | - |
| Dec 2022 | - | $532.20 K |
| Dec 2021 | $314.80 K | - |
FAQ
- What is Serina Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Serina Therapeutics?
- What is Serina Therapeutics annual cash & cash equivalents year-on-year change?
- What is Serina Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Serina Therapeutics?
- What is Serina Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Serina Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SER is $532.20 K
What is the all time high annual cash & cash equivalents for Serina Therapeutics?
Serina Therapeutics all-time high annual cash & cash equivalents is $532.20 K
What is Serina Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SER annual cash & cash equivalents has changed by +$217.40 K (+69.06%)
What is Serina Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SER is $3.19 M
What is the all time high quarterly cash and cash equivalents for Serina Therapeutics?
Serina Therapeutics all-time high quarterly cash and cash equivalents is $8.72 M
What is Serina Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SER quarterly cash and cash equivalents has changed by $0.00 (0.00%)